FIUME, Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 2.965
AS - Asia 1.482
EU - Europa 888
SA - Sud America 208
Continente sconosciuto - Info sul continente non disponibili 115
AF - Africa 42
OC - Oceania 4
Totale 5.704
Nazione #
US - Stati Uniti d'America 2.837
SG - Singapore 705
IT - Italia 431
CN - Cina 351
BR - Brasile 159
DE - Germania 135
VN - Vietnam 116
IN - India 108
CA - Canada 73
SE - Svezia 72
HK - Hong Kong 57
GB - Regno Unito 56
FI - Finlandia 52
BD - Bangladesh 33
RU - Federazione Russa 33
IL - Israele 19
NL - Olanda 19
ZA - Sudafrica 18
MX - Messico 17
FR - Francia 16
AR - Argentina 14
ES - Italia 14
PL - Polonia 13
ID - Indonesia 12
JP - Giappone 12
UA - Ucraina 11
SC - Seychelles 9
CL - Cile 8
PE - Perù 8
TR - Turchia 8
AT - Austria 7
SA - Arabia Saudita 7
CR - Costa Rica 6
EC - Ecuador 6
CZ - Repubblica Ceca 5
GP - Guadalupe 5
GT - Guatemala 5
IQ - Iraq 5
KR - Corea 5
PR - Porto Rico 5
AE - Emirati Arabi Uniti 4
CW - ???statistics.table.value.countryCode.CW??? 4
ET - Etiopia 4
KZ - Kazakistan 4
NP - Nepal 4
PY - Paraguay 4
RO - Romania 4
SV - El Salvador 4
AU - Australia 3
BE - Belgio 3
CH - Svizzera 3
CO - Colombia 3
EU - Europa 3
HN - Honduras 3
LT - Lituania 3
MY - Malesia 3
NI - Nicaragua 3
PK - Pakistan 3
TH - Thailandia 3
UZ - Uzbekistan 3
VE - Venezuela 3
AM - Armenia 2
DZ - Algeria 2
EG - Egitto 2
GD - Grenada 2
IE - Irlanda 2
IR - Iran 2
JM - Giamaica 2
JO - Giordania 2
MA - Marocco 2
MD - Moldavia 2
MN - Mongolia 2
PH - Filippine 2
SY - Repubblica araba siriana 2
TN - Tunisia 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
DK - Danimarca 1
GR - Grecia 1
KE - Kenya 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
LI - Liechtenstein 1
LK - Sri Lanka 1
MM - Myanmar 1
NG - Nigeria 1
OM - Oman 1
PA - Panama 1
PW - Palau 1
RS - Serbia 1
SI - Slovenia 1
SN - Senegal 1
SR - Suriname 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 5.597
Città #
San Jose 486
Dallas 365
Singapore 274
Ashburn 238
Chandler 198
Santa Clara 110
Munich 100
Council Bluffs 86
Milan 84
Bengaluru 81
Hefei 81
Beijing 80
Princeton 71
Lawrence 70
Catanzaro 55
Hong Kong 55
Ho Chi Minh City 45
Turku 45
Wilmington 44
Seattle 38
Boardman 33
Los Angeles 33
Ottawa 32
London 31
Chicago 29
Phoenix 27
Naples 25
Hanoi 24
Des Moines 18
New York 18
São Paulo 18
Montreal 15
Napoli 15
Rome 14
Shanghai 14
Redmond 12
San Francisco 12
Taranto 11
Boston 10
Johannesburg 10
Tokyo 10
Augusta 9
Brooklyn 9
Warsaw 9
Amsterdam 8
Marano 8
Rio de Janeiro 8
Foggia 7
Helsinki 7
Mexico City 7
Paris 7
Stockholm 7
Buffalo 6
Reggio Calabria 6
The Dalles 6
Vienna 6
Denver 5
Falls Church 5
Guangzhou 5
Houston 5
Manchester 5
Norwalk 5
Olomouc 5
Orem 5
Philadelphia 5
Riyadh 5
Shenzhen 5
Teresina 5
Toronto 5
Assago 4
Can Tho 4
Chennai 4
Hanover 4
Jiaxing 4
Latina 4
Madrid 4
Mumbai 4
Ninh Bình 4
Pune 4
Redwood City 4
San José 4
San Salvador 4
Verona 4
Willemstad 4
Xi'an 4
Addis Ababa 3
Asunción 3
Aversa 3
Bangkok 3
Bari 3
Bologna 3
Buenos Aires 3
Cabo Frio 3
Campo Largo 3
Cape Town 3
Charlotte 3
Chieti 3
Cleveland 3
Columbus 3
Cosenza 3
Totale 3.301
Nome #
Early molecular and behavioral response to lipopolysaccharide in the WAG/Rij rat model of absence epilepsy and depressive-like behavior, involves interplay between AMPK, AKT/mTOR pathways and neuroinflammatory cytokine release 165
Activation of NF-κB in B cell receptor signaling through Bruton’s tyrosine kinase-dependent phosphorylation of IκB-α 157
Monitoring multiple myeloma by idiotype-specific peptide binders of tumor-derived exosomes 111
A novel phage display based platform for exosome diversity characterization 107
Btk regulation in human and mouse B cells via protein kinase C phosphorylation of IBtkγ. 105
Activation of NF-κB in B cell receptor signaling through Bruton's tyrosine kinase-dependent phosphorylation of IκB-α 103
Aberrant Glycosylation as Biomarker for Cancer: Focus on CD43 101
Btk regulation in human and mouse B cells via protein kinase C phosphorylation of IBtk-gamma 96
B-cell receptor-guided delivery of peptide-siRNA complex for B-cell lymphoma therapy 96
Evidence for a novel Cullin-3/IBtk human ubiquitin ligase complex 94
CRL3IBTK Regulates the Tumor Suppressor Pdcd4 through Ubiquitylation Coupled to Proteasomal Degradation 93
Eukaryotic Initiation Factor 4H Is under Transcriptional Control of p65/NF-kappaB 93
Detection of chronic lymphocytic leukemia subpopulations in peripheral blood by phage ligands of tumor immunoglobulin B cell receptors 89
IBTK contributes to B-cell lymphomagenesis in Eμ-myc transgenic mice conferring resistance to apoptosis 89
CRL3IBTK regulates the tumor suppressor Pdcd4 through ubiquitylation coupled to proteasomal degradation 89
Crucial role for IBtk in the survival and maintenance of mature B cells 88
FABP5 is a key player in metabolic modulation and NF-κB dependent inflammation driving pleural mesothelioma 85
Development of Cyclic Peptides Targeting the Epidermal Growth Factor Receptor in Mesenchymal Triple-Negative Breast Cancer Subtype 84
Metabolites profiling of melanoma interstitial fluids reveals uridine diphosphate as potent immune modulator capable of limiting tumor growth 84
Cancer-associated CD43 glycoforms as target of immunotherapy 84
Phage-displayed peptides for targeting tyrosine kinase membrane receptors in cancer therapy 83
Human immunodeficiency virus-1 Tat activates NF-kappaB via physical interaction with IkappaB-alpha and p65 82
Design and Characterization of a Peptide Mimotope of the HIV-1 gp120 Bridging Sheet 82
IkappaB-alpha Represses the Transcriptional Activity of the HIV-1 Tat Transactivator by Promoting Its Nuclear Export 81
Predominant VH1-69 IgBCR Clones Show Higher Expression of CD5 in Heterogeneous Chronic Lymphocytic Leukemia Populations 81
Evidence of shared epitopic reactivity among independent B-cell clones in Chronic Lymphocytic Leukemia patients 80
Cancer-associated CD43 glycoforms as target of immunotherapy 78
Abstract 1814: Harnessing the potential of idiotypic peptide therapy for the treatment of multiple myeloma 77
The expression of Inhibitor of Bruton’s Tyrosine kinase gene is progressively up regulated in the clinical course of chronic lymphocytic leukemia conferring resistance to apoptosis 76
Computational analysis and in vivo validation of a microRNA encoded by the IBTK gene, a regulator of B-lymphocytes differentiation and survival 76
Molecular modelling of epitopes recognized by neoplastic B lymphocytes in Chronic Lymphocytic Leukemia 76
Inhibition of HIV-1 replication in primary human monocytes by the IkappaB-alfaS32/36A repressor of NF-kappaB 74
Biological control of corky root in tomato 73
The aftermath of the Merck's HIV vaccine trial 73
Impairment of T cell development and acute inflammatory response in HIV-1 Tat transgenic mice 72
Evidence of shared epitopic reactivity among independent B-cell clones in chronic lymphocytic leukemia patients 70
Biological control of Botrytis gray mould and Sclerotinia drop in lettuce 69
IBtkα Activates the β‐Catenin‐Dependent Transcription of MYC through Ubiquitylation and Proteasomal Degradation of GSK3βin Cancerous B Cells 69
Generation and Characterization of a Tumor Stromal Microenvironment and Analysis of Its Interplay with Breast Cancer Cells: An In Vitro Model to Study Breast Cancer-Associated Fibroblast Inactivation 68
IBTK differently modulates gene expression and RNA splicing in hela and K562 cells 68
Unmutated IGHV1-69 CLL Clone Displays a Distinct Gene Expression Profile by a Comparative qRT-PCR Assay 66
Id-peptides as new tools for diagnosis and treatment of B-cell Chronic Lymphocytic Leukemia (B-CLL) 66
IBTK Haploinsufficiency Affects the Tumor Microenvironment of Myc-Driven Lymphoma in E- myc Mice 66
Role of Chronic Lymphocytic Leukemia (CLL)-Derived Exosomes in Tumor Progression and Survival 66
Metabolic Plasticity of Melanoma Cells and Their Crosstalk With Tumor Microenvironment 66
The Lack of STING Impairs the MHC-I Dependent Antigen Presentation and JAK/STAT Signaling in Murine Macrophages 64
Harnessing the potential of idiotypic peptide therapy for the treatment of multiple myeloma 64
The expression of inhibitor of bruton's tyrosine kinase gene is progressively up regulated in the clinical course of chronic lymphocytic leukaemia conferring resistance to apoptosis 64
Crucial role for IBtkgamma in the survival and maintenance of matureB cells 62
Id-peptides as biomarkers of B-cell Chronic Lymphocytic Leukemia 61
miRNA-23a modulates sodium-hydrogen exchanger 1 expression: studies in medullary thick ascending limb of salt induced hypertensive rats 61
Thyroid Cancer and Fibroblasts 61
Insights into Thymus Development and Viral Thymic Infections 59
Insights about myc and apoptosis in b-lymphomagenesis: An update from murine models 59
Mass spectrometry-based identification of the tumor antigen UN1 as the transmembrane CD43 sialoglycoprotein 59
Mass spectrometry-based identification of the tumor antigen UN1 as the transmembrane CD43 sialoglycoprotein 56
Id peptide-based methodology to explore the antigenic diversity of B-cell Chronic Lymphocytic Leukemia (B-CLL) 55
Uncovering the Exosomes Diversity: A Window of Opportunity for Tumor Progression Monitoring 55
Molecular T-Cell Repertoire Analysis as Source of Prognostic and Predictive Biomarkers for Checkpoint Blockade Immunotherapy 53
Biological control of Botrytis gray mould on tomato cultivated in greenhouse 52
Enhanced pro-apoptotic activity of rituximab through IBTK silencing in non-Hodgkin lymphoma B-cells 51
Guardians and Mediators of Metastasis: Exploring T Lymphocytes, Myeloid-Derived Suppressor Cells, and Tumor-Associated Macrophages in the Breast Cancer Microenvironment. 51
Structural and functional insights into IκB-α/HIV-1 Tat interaction. 51
Molecular modeling of epitopes recognized by neoplastic B-cells in Chronic Lymphocytic Leukemia 49
Development of a Stromal Microenvironment Experimental Model Containing Proto-Myofibroblast Like Cells and Analysis of Its Crosstalk with Melanoma Cells: A New Tool to Potentiate and Stabilize Tumor Suppressor Phenotype of Dermal Myofibroblasts 48
Influence of tumor microenvironment and fibroblast population plasticity on melanoma growth, therapy resistance and immunoescape 45
Editorial: Tumor Microenvironment and Cancer Cell Interactions in Solid Tumor Growth and Therapy Resistance 44
Field response of some asparagus varieties to rust, Fusarium crown root rot, and violet root rot 44
Physical and functional characterization of the genetic locus of IBtk, an inhibitor of Bruton's tyrosine kinase: evidence for three protein isoforms of IBtk 44
Peptide binders of BCR as a novel tool to target mature and clonogenic tumor cells in Multiple Myeloma 44
Generation and analysis of spheroids from human primary skin myofibroblasts: an experimental system to study myofibroblasts deactivation 41
Revisiting Bacterial Ubiquitin Ligase Effectors: Weapons for Host Exploitation 40
The Inhibitor Of Bruton’ Tyrosine Kinase-G Regulates The Btk Signaling In B Cells 39
Influence of fibroblasts on mammary gland development, breast cancer microenvironment remodeling, and cancer cell dissemination 39
Exacerbation of Allergic Airway Inflammation in Mice Lacking ECTO-5′-Nucleotidase (CD73) 38
Rapamycin modulates lipopolysaccharide-induced neuroinflammatory response and absence seizures in in a genetic rat model of absence epilepsy 37
Peptide binders of BCR as a novel tool to target mature and clonogenic tumor cells in Multiple Myeloma 34
Mass Spectrometry-Based Identification of a Tumor Sialoglycoprotein Antigen involved in Cancer Progression 34
Role of Bruton Tyrosine Kinase in B cell signaling and NF-kappaB regulation 34
IBTK Differently Modulates Gene Expression and RNA Splicing in HeLa and K562 Cells 31
Use of Filtrates of Pyrenochaeta lycopersici in Tests for Selecting Tolerant Varieties of Tomato 31
Efficacia nematocida dell’oxamyl da solo ed integrato 28
Uridine diphosphate drives myeloid differentiation and functional reprogramming through dynamic transcriptional network 24
The 1α,25-dihydroxyvitamin D3 modulates T cell activation and immune checkpoint pathways in human T cells 21
Lysosomal vulnerability as a therapeutic target in thyroid cancer using fucoidan nanoparticles 20
null 6
Totale 5.704
Categoria #
all - tutte 47.101
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.101


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022203 0 0 0 0 14 13 19 81 12 32 28 4
2022/2023633 141 32 42 18 69 43 5 55 117 43 49 19
2023/2024328 65 41 31 21 24 65 5 18 4 6 13 35
2024/20251.095 146 44 46 33 83 120 30 28 154 34 160 217
2025/20262.414 145 257 416 254 223 122 309 147 263 135 84 59
2026/2027732 26 92 280 233 101 0 0 0 0 0 0 0
Totale 5.704